Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark White

Surgery Daytona Beach, FL Medical Doctor

NPI 1477559631 CMS profile 112324

103 Memorial Medical Pkwy Ste 125, Daytona Beach, FL 32117

Open in the dashboard

General payments

$16,400

223 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mark White of Daytona Beach, FL is reported in the CMS Open Payments database as having received $16,400 across 223 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $683 26
2024 General $9,728 32
2023 General $2,885 52
2022 General $584 29
2021 General $710 36
2020 General $342 18
2019 General $1,468 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark White
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Mark White were reported at $683. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Mark White Surgery median Middle half National median
2019 $1,468 $253 $82–$1,521 $163
2020 $342 $131 $40–$706 $114
2021 $710 $168 $50–$904 $132
2022 $584 $224 $76–$1,218 $149
2023 $2,885 $253 $82–$1,255 $160
2024 $9,728 $279 $90–$1,381 $164
2025 $683 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $10,367 22 payments
  2. Medical Device Business Services, Inc. $978 7 payments
  3. W. L. Gore & Associates, Inc. $941 10 payments
  4. Daiichi Sankyo Inc. $458 18 payments
  5. Novartis Pharmaceuticals Corporation $423 20 payments
  6. AstraZeneca Pharmaceuticals LP $255 10 payments
  7. Dilon Technologies, Inc. $246 9 payments
  8. Merck Sharp & Dohme Corporation $212 7 payments
  9. Lilly USA, LLC $207 11 payments
  10. Ethicon US, LLC $195 9 payments
  11. Other $2,116 100 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $8,000 1 payment
  2. Food and Beverage $5,656 211 payments
  3. Travel and Lodging $2,728 10 payments
  4. Gift $16 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $10,367 22 payments
  2. LINX Reflux Management System $1,057 10 payments
  3. GORE BIO-A Tissue Reinforcement $812 6 payments
  4. ENHERTU $458 18 payments
  5. HEMOBLAST BELLOWS $215 8 payments
  6. KISQALI $210 10 payments
  7. VERZENIO $207 11 payments
  8. KEYTRUDA $196 6 payments
  9. RETEVMO $144 7 payments
  10. TUKYSA $140 7 payments
  11. Other $4,073 183 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

139

Median for General Surgery: 59

Drug cost

$590

Median for General Surgery: $393

Branded share of claims

87.1%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 103 $367
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 18 $141
Cephalexin Generic 18 $82

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$80,292

Medicare's payments for the services billed

Medicare patients

245

Average age 75

Services billed

578

160 women, 85 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Cancer 44%
Ischemic heart disease 33%
Chronic kidney disease 32%
Diabetes 26%
COPD 23%
Depression 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ENHERTU
  • Daiichi Sankyo Inc. $100
  • AstraZeneca Pharmaceuticals LP $52
$151 — —
IMFINZI
  • AstraZeneca Pharmaceuticals LP $87
$87 — —
JAKAFI
  • Incyte Corporation $31
$31 — —
KEYTRUDA
  • Merck Sharp & Dohme Corporation $24
$24 — —
KISQALI
  • Novartis Pharmaceuticals Corporation $24
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

223 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record